We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Neonatal severe hyperparathyroidism: further clinical and molecular delineation.
- Authors
Al-Khalaf, Fawziya A; Ismail, Adel; Soliman, Ashraf T; Cole, David E C; Ben-Omran, Tawfeg
- Abstract
We report a newborn female from a consanguineous Sri Lankan family with clinical and biochemical features of neonatal severe hyperparathyroidism (NSHPT). Mutation screening of the calcium-sensing receptor (CASR) gene in genomic DNA revealed a homozygous truncating mutation (c.679C>T, predicting p.R227X), confirming the clinical diagnosis. Other mutations at the R227 position are reported to cause varying degrees of hypercalcemia and hyperparathyroidism, but this nonsense variant is novel and expected to induce unremitting hyperparathyroidism from birth onward. In our patient with NSHPT, early bisphosphonate therapy was crucial in counteracting the marked hypercalcemia and allowed for safe surgical intervention ("total" parathyroidectomy, "thymectomy and hemithyroidectomy") at 3 months of age.
- Publication
European journal of pediatrics, 2011, Vol 170, Issue 5, p625
- ISSN
1432-1076
- Publication type
Journal Article
- DOI
10.1007/s00431-010-1335-z